Visual hallucinations were often triggered by a small increase in the dose of dopaminergic medications and would initially be amenable to the adjustment of anti-parkinsonian medications or the introduction of a cholinesterase inhibitor. This evidence concerns the gene BCHE and Visual hallucination.